Exchange Announcement • 08 Nov 2024 05:05
Exchange Announcement • 07 Nov 2024 20:05
Exchange Announcement • 09 Aug 2024 04:10
Exchange Announcement • 08 Aug 2024 19:10
Exchange Announcement • 08 Jun 2024 04:03
ENTITY
Geron Corp (GERN US)
Geron Corp (GERN US)
3
Analysis
Health Care • United States
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
more
x